Edward M. Kaye M.D.
CEO at Stoke Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 2 boards, counting each seat separately. Longest: Cytokinetics Incorporated, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cytokinetics Incorporated May 27, 202697.0%
-
Stoke Therapeutics Inc. June 3, 202587.4%
-
Cytokinetics Incorporated May 10, 202362.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 16, 2026 | Cytokinetics Incorporated | Grant or award | +195 | $63.92 | $12,464 |
| Aug 18, 2026 | Stoke Therapeutics Inc. | Open-market sale | −11,930 | $32.01 | $381,879 |
| Aug 18, 2026 | Stoke Therapeutics Inc. | Open-market sale | −637 | $32.47 | $20,683 |
| Aug 14, 2026 | Stoke Therapeutics Inc. | Option exercise | +26,250 | — | — |
| Jul 15, 2026 | Cytokinetics Incorporated | Grant or award | +151 | $82.62 | $12,476 |
| Jun 1, 2026 | Cytokinetics Incorporated | Open-market sale | −2,933 | $76.09 | $223,172 |
| May 27, 2026 | Cytokinetics Incorporated | Grant or award | +2,851 | — | — |
| Apr 15, 2026 | Cytokinetics Incorporated | Grant or award | +191 | $65.37 | $12,486 |
| Mar 15, 2026 | Stoke Therapeutics Inc. | Option exercise | +35,500 | — | — |
| Mar 15, 2026 | Stoke Therapeutics Inc. | Option exercise | +26,250 | — | — |
| Jan 15, 2026 | Cytokinetics Incorporated | Grant or award | +197 | $63.44 | $12,498 |
| Dec 8, 2025 | Stoke Therapeutics Inc. | Open-market sale | −3,825 | $31.44 | $120,258 |
| Dec 8, 2025 | Stoke Therapeutics Inc. | Open-market sale | −8,274 | $32.52 | $269,070 |
| Dec 8, 2025 | Stoke Therapeutics Inc. | Open-market sale | −1,331 | $33.10 | $44,056 |
| Dec 5, 2025 | Stoke Therapeutics Inc. | Open-market sale | −6,367 | $31.33 | $199,478 |
Questions about Edward M. Kaye M.D.
What boards is Edward M. Kaye M.D. on?
Edward M. Kaye M.D. sits on the boards of Cytokinetics Incorporated and Stoke Therapeutics Inc.
What company is Edward M. Kaye M.D. the CEO of?
Edward M. Kaye M.D. is CEO of Stoke Therapeutics Inc.
How long has Edward M. Kaye M.D. served on boards?
Our records show at least 8 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.